← Scoopfeeds — Intelligent news, curated.
AstraZeneca advances weight-loss pill to take aim at obesity leaders
business

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Financial Times · Jun 8, 2026, 8:15 PM · Also reported by 1 other source

Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly

Read full story on Financial Times → More top stories

Also covered by

STAT News STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

More in business

Yahoo Finance
CyberCube lands first Austrian client
Investing.com
Musk’s Starlink leads Bezos’ Amazon as airlines rush to boost in-flight Wi-Fi
Investing.com
Wall St futures tick up as chips extend gains
Investing.com
Analysis-Fuel price shock to widen product gap between US airlines
Investing.com
UK’s CMA opens probe into Paramount Skydance’s Warner Bros. bid
Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop